10.16.00: Specialty Pharmaceuticals, Generics & Drug Delivery Companies Issue
Five leading analysts and top management from thirty-three sector firms examine the outlook for Specialty Pharmaceuticals, Generics & Drug Delivery Companies in this special 166-page issue from The Wall Street Transcript.
  1. Specialty Pharmaceuticals, Generics & Drug Delivery Companies - In an in-depth (13,400 words) Analyst Roundtable, Andrew Forman, Director at UBS Warburg, Ian Sanderson, Managing Director, Institutional Research at SG Cowen Securities, Jerry Treppel, Managing Director at Banc of America Securities LLC, and Alex Zisson, Managing Director and Senior Pharmaceutical Analyst with Chase H&Q, examine the outlook for the sector, including patent expirations, industry tiering, and share specific stock recommendations.
  2. Specialty Pharmaceuticals Stocks - In an-depth (4,500 words) Analyst Interview, Parice Halbert, Senior Analyst at American Express Financial Corp., examines the outlook for the sector, including medium-capitalization pharmaceutical companies, product pipelines, and shares specific stock recommendations.
  3. The TWST confidential Off-The-Record survey of management performance at twelve sector firms asked market insiders about the ability of management teams to create shareholder value. Firms reviewed in Off-The-Record include:
    ALZA, Andrx, Biovail, Elan, Forest Laboratories, Inhale Therapeutic Systems, IVAX, King Pharmaceuticals, Medicis Pharmaceutical, Mylan Laboratories, Sepracor, Watson Pharmaceuticals
  4. CEO interviews (average 2,500 words). Top management of thirty-three sector firms examine the outlook for their firm and the sector. Firms include:
    Andrx, CollaGenex Pharmaceuticals, Discovery Partners International, Elite Pharmaceuticals, Entropin, Flemington Pharmaceutical, Matrix Pharmaceutical, Nastech Pharmaceutical, PRAECIS PHARMACEUTICALS, Weston Medical Group, 3-Dimensional Pharmaceuticals, Access Worldwide Communications, Aradigm, Atrix Laboratories, Axonyx, Bioject Medical Technologies, Bradley Pharmaceuticals, Chronimed, Cortex Pharmaceuticals, Cyclo3pss, Elast Technologies, Endorex, Hemagen Diagnostics, LecTec, Lescarden, MGI Pharma, Nortran Pharmaceuticals, OraPharma, Pain Therapeutics, Palatin Technologies, SeraCare, Specialized Health Products International, Techniclone
    5. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE